CEO SUMMARY: An entrepreneur in the liquid biopsy sector outlines a series of questions to answer if a diagnostic innovation is to ever succeed in the commercial marketplace. Scientists and businesspeople will want to ask about a potential product’s significance, uniqueness, and soundness. Those questions will help determine a product’s true value to its target […]
Translating Genomic Testing to the Clinic
How to turn scientific research into a viable busi- ness plan for real-world diagnostic applications
- By Mark Terry
- > From the Volume XXXIII, No. 1 - January 19, 2026 Issue
- Tags: Belay Diagnostics, Brian Coe, cerebral spinal fluid, CSF, executive war college, genomic testing, genomics, Johns Hopkins, lab risk & compliance, LabCorp, liquid biopsy, net present value, NPV, Quest Diagnostics, Research Policy, SBIR, small business innovation research grant, small business technology transfer grant, STTR, University of Minnesota
